Yvonne Lin-Liu

Dr. Yvonne Lin-Liu is a Board Certified Gynecologic Oncologist and Staff Physician in the Division of Gynecologic Oncology within the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco (UCSF). She specializes in treating gynecologic cancers with a patient-centered approach, focusing on helping patients understand their disease biology and available treatment options, particularly serving women seeking second opinions.

Dr. Lin-Liu's educational background includes:

• SB in Chemistry from Massachusetts Institute of Technology (1993)
• MS in Epidemiology from Harvard School of Public Health (1995)
• MD from University of California-Irvine College of Medicine (2001)
• Residency in Obstetrics & Gynecology from Beth Israel Deaconess Medical Center (2005)
• Fellowship in Gynecologic Oncology from The University of Texas M.D. Anderson Cancer Center (2009)

Her research focuses on molecular mechanisms of gynecologic cancers, particularly examining the role of glucose-regulated protein-78 (GRP78), AKT signaling pathways, and the impact of obesity on cellular stress in endometrial cancer development. She has investigated natural compounds like curcumin for cancer treatment and explored the relationship between chronic stress and cancer progression. Her work bridges basic science discoveries with clinical applications to improve patient outcomes.

Analysis of her publication record reveals a consistent trajectory in gynecologic oncology research, with emphasis on molecular pathways in endometrial and ovarian cancers. Her work spans from fundamental molecular investigations to clinical studies examining treatment patterns, demonstrating an integrated approach to cancer research that connects laboratory findings with patient care considerations.

Dr. Lin-Liu has received significant recognition for her contributions to the field:

• NIH/NCI Career Development Award (2013)
• Gynecologic Cancer Foundation/St. Louis Ovarian Cancer Awareness Research Award (2011)

Dr. Lin-Liu was previously an NCI-funded physician-scientist at UCSF studying obesity's impact on endometrial cancer before joining Genentech in 2014 as a Group Medical Director. Despite her industry role, she maintains active clinical practice, believing direct patient care is essential to developing effective cancer therapies. She serves on various professional society committees focused on development and editorial boards of prominent journals, demonstrating ongoing commitment to academic medicine.

She is an active member of the Society of Gynecologic Oncology, Western Association of Gynecologic Oncologists, American Association for Cancer Research, and American Society of Clinical Oncology, contributing to the broader cancer research community through these professional affiliations.